Open AccessSAVE-AMD: Safety of VEGF Inhibitors in Age-Related Macular Degeneration
Author(s) -
Frank Enseleit,
Stephan Michels,
Isabella Sudano,
Marc Stahel,
Sandrine Zweifel,
Oliver Schlager,
Matthias Becker,
Stephan Winnik,
Matthias P. Nägele,
Andreas J. Flammer,
Michel Neidhart,
Nicole Graf,
Christian M. Matter,
Burkhardt Seifert,
Thomas F. Lüscher,
Frank Ruschitzka
Publication year - 2017
Publication title -
ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.639
H-Index - 60
eISSN - 1423-0267
pISSN - 0030-3755
DOI - 10.1159/000478665
Subject(s) - macular degeneration , medicine , ranibizumab , bevacizumab , pro re nata , ophthalmology , clinical endpoint , prospective cohort study , vascular endothelial growth factor , clinical trial , surgery , vegf receptors , chemotherapy
To determine whether intraocular treatment with vascular endothelial growth factor (VEGF) inhibitors change systemic endothelial function (EF) in patients with neovascular age-related macular degeneration (AMD).